About Us Understanding GvHD Insights & stories >  Real-life stories >  Expert insights Support groups GvHD Day Resources >  Post-transplant GvHD symptom tracker >  Extracorporeal photopheresis (ECP) >  GvHD Day 2025

How do physicians decide which treatment to use in patients with GvHD?

How do physicians decide which treatment to use in patients with GvHD?

Hildegard Greinix, Austria

Know GvHD was pleased to speak to Hildegard Greinix, Medical University of Vienna, Austria. We asked, How do physicians decide which treatment to use in patients with graft-versus-host disease (GvHD)?

Greinix explains that GvHD can affect people in different ways, depending on which organs are involved – such as the skin, eyes, liver, gut, or lungs – and how severe the symptoms are. She describes various treatment options for different types of GvHD, with a focus on treatments for steroid-refractory chronic GvHD, including recent findings from a clinical trial of extracorporeal photopheresis plus ruxolitinib.

v2.28.04